European Medicines Agency recommends the approval of thalidomide for the treatment of rare bone-marrow cancer

View source ↗

Summary

The EMA recommends approval of thalidomide for a rare bone-marrow cancer, indicating potential access to a new treatment option for this indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Cancer

Drugs mentioned

• Thalidomide (thalidomide)